Image For Activity Cover
8 Hour MOUD Training
Overview


With the passing of the MATE Act, all clinicians applying for their initial DEA registration or seeking renewal are required to complete 8 hours of accredited training in the treatment and management of patients with opioid or other substance use disorders (SUD)

This 8-hour MOUD course satisfies that requirement.  It is intended for practitioners with limited SUD training who seek an overview of foundational topics. It includes 8 modules that are considered to provide a strong foundation in SUD. They provide an overview of SUD; screening, assessment, and initiation of SUD treatment; addressing stigma and use of appropriate medical terminology and language; medication treatments for opioid and alcohol use disorders; opioid analgesics and pain; other SUDs (e.g., stimulant and benzodiazepine use disorder); and opioid overdose education and naloxone.

It is important to note that each individual module will provide its own CE certificate.  You will need to claim each CE certificate individually after you have completed that module.  After you have completed all the modules the final certificate will indicate you completed the 8 Hour MOUD Training.  The PDF containing that final certificate will also provide each individual CE certificate.  If you have not yet claimed that certificate, that CE will be blank.

Please note that if you have already completed any of these SUD 101 Core Curriculum modules, they will be marked as complete within the 8 Hour MOUD Training.  However any progress made on the previous version of the 8 Hour Buprenorphine Training will NOT count towards this new training. 
Summary
Availability: On-Demand
Cost: FREE
Credit Offered:
8.5 CME Credits
8.5 PA-CME Credits
8.5 Other Professionals Credits
8.5 Nursing Credits
8.5 Pharmacy Credits
8.5 IPCE Credits
Contains: 8 Courses
Recommended
 
The content on this site is intended solely to inform and educate medical professionals. This site shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional.



Funding for this initiative was made possible (in part) by grant nos. 1H79TI086770 and 1H79TI085588 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

 
PCSS-MOUD
PCSS-MOUD.org
pcss@aaap.org
For Buprenorphine Training Inquiries, email PCSS-MOUD.

ORN
opioidresponsenetwork.org

Powered By